Cargando…
Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes
BACKGROUND: Packed red blood cell transfusion may improve oxygen content in single‐ventricle neonates, but its effect on clinical outcomes after Stage 1 palliation is unknown. METHODS AND RESULTS: Retrospective multicenter analysis of packed red blood cell transfusion exposures in neonates after Sta...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660859/ https://www.ncbi.nlm.nih.gov/pubmed/32390527 http://dx.doi.org/10.1161/JAHA.119.015304 |
_version_ | 1783609098732830720 |
---|---|
author | Mille, Felina K. Badheka, Aditya Yu, Priscilla Zhang, Xuemei Friedman, David F. Kheir, John van den Bosch, Sarah Cabrera, Antonio G. Lasa, Javier J. Katcoff, Hannah Hu, Paula Borasino, Santiago Hock, Krissie Huskey, Jordan Weller, Jamie Kothari, Harsh Blinder, Joshua |
author_facet | Mille, Felina K. Badheka, Aditya Yu, Priscilla Zhang, Xuemei Friedman, David F. Kheir, John van den Bosch, Sarah Cabrera, Antonio G. Lasa, Javier J. Katcoff, Hannah Hu, Paula Borasino, Santiago Hock, Krissie Huskey, Jordan Weller, Jamie Kothari, Harsh Blinder, Joshua |
author_sort | Mille, Felina K. |
collection | PubMed |
description | BACKGROUND: Packed red blood cell transfusion may improve oxygen content in single‐ventricle neonates, but its effect on clinical outcomes after Stage 1 palliation is unknown. METHODS AND RESULTS: Retrospective multicenter analysis of packed red blood cell transfusion exposures in neonates after Stage 1 palliation, excluding those with intraoperative mortality or need for extracorporeal membrane oxygenation. Transfusion practice variability was assessed, and multivariable regression used to identify transfusion risk factors. After propensity score adjustment for severity of illness, clinical outcomes were compared between transfused and nontransfused subjects. Of 396 subjects, 323 (82%) received 930 postoperative red blood cell transfusions. Packed red blood cell volume (median 9–42 mL/kg [P<0.0001]), donor exposures (1–2 [P<0.0001]), transfusion number (1–3 [P<0.0001]), and pretransfusion hemoglobin (12.1–13 g/dL, P=0.0049) varied between sites. Cyanosis (P=0.02), chest tube output (P=0.0003), and delayed sternal closure (P=0.0033) increased transfusion risk. Transfusion was associated with prolonged mechanical ventilation (6 [interquartile range 4, 12] versus 3 [1, 5] days, P=0.02) and intensive care unit stay (19 [12, 33] versus 9 [6, 19] days, P=0.016). When stratified by number of transfusions (0, 1, or >1), duration of mechanical ventilation (3 [1, 5] versus 4 [3, 6] versus 9 [5, 16] days [P<0.0001]) and intensive care unit stay (9 [6, 19] versus 13 [8, 25] versus 21 [13, 38] days [P<0.0001]) increased for those transfused more than once. Most subjects who died were transfused, though the association with mortality was not significant. CONCLUSIONS: Packed red blood cell transfusion after Stage 1 palliation is common, and transfusion practice is variable. Transfusion is a significant predictor of longer intensive care unit stay and mechanical ventilation. Further studies to define evidence‐based transfusion thresholds are warranted. |
format | Online Article Text |
id | pubmed-7660859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76608592020-11-17 Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes Mille, Felina K. Badheka, Aditya Yu, Priscilla Zhang, Xuemei Friedman, David F. Kheir, John van den Bosch, Sarah Cabrera, Antonio G. Lasa, Javier J. Katcoff, Hannah Hu, Paula Borasino, Santiago Hock, Krissie Huskey, Jordan Weller, Jamie Kothari, Harsh Blinder, Joshua J Am Heart Assoc Original Research BACKGROUND: Packed red blood cell transfusion may improve oxygen content in single‐ventricle neonates, but its effect on clinical outcomes after Stage 1 palliation is unknown. METHODS AND RESULTS: Retrospective multicenter analysis of packed red blood cell transfusion exposures in neonates after Stage 1 palliation, excluding those with intraoperative mortality or need for extracorporeal membrane oxygenation. Transfusion practice variability was assessed, and multivariable regression used to identify transfusion risk factors. After propensity score adjustment for severity of illness, clinical outcomes were compared between transfused and nontransfused subjects. Of 396 subjects, 323 (82%) received 930 postoperative red blood cell transfusions. Packed red blood cell volume (median 9–42 mL/kg [P<0.0001]), donor exposures (1–2 [P<0.0001]), transfusion number (1–3 [P<0.0001]), and pretransfusion hemoglobin (12.1–13 g/dL, P=0.0049) varied between sites. Cyanosis (P=0.02), chest tube output (P=0.0003), and delayed sternal closure (P=0.0033) increased transfusion risk. Transfusion was associated with prolonged mechanical ventilation (6 [interquartile range 4, 12] versus 3 [1, 5] days, P=0.02) and intensive care unit stay (19 [12, 33] versus 9 [6, 19] days, P=0.016). When stratified by number of transfusions (0, 1, or >1), duration of mechanical ventilation (3 [1, 5] versus 4 [3, 6] versus 9 [5, 16] days [P<0.0001]) and intensive care unit stay (9 [6, 19] versus 13 [8, 25] versus 21 [13, 38] days [P<0.0001]) increased for those transfused more than once. Most subjects who died were transfused, though the association with mortality was not significant. CONCLUSIONS: Packed red blood cell transfusion after Stage 1 palliation is common, and transfusion practice is variable. Transfusion is a significant predictor of longer intensive care unit stay and mechanical ventilation. Further studies to define evidence‐based transfusion thresholds are warranted. John Wiley and Sons Inc. 2020-05-11 /pmc/articles/PMC7660859/ /pubmed/32390527 http://dx.doi.org/10.1161/JAHA.119.015304 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Mille, Felina K. Badheka, Aditya Yu, Priscilla Zhang, Xuemei Friedman, David F. Kheir, John van den Bosch, Sarah Cabrera, Antonio G. Lasa, Javier J. Katcoff, Hannah Hu, Paula Borasino, Santiago Hock, Krissie Huskey, Jordan Weller, Jamie Kothari, Harsh Blinder, Joshua Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes |
title | Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes |
title_full | Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes |
title_fullStr | Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes |
title_full_unstemmed | Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes |
title_short | Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes |
title_sort | red blood cell transfusion after stage i palliation is associated with worse clinical outcomes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660859/ https://www.ncbi.nlm.nih.gov/pubmed/32390527 http://dx.doi.org/10.1161/JAHA.119.015304 |
work_keys_str_mv | AT millefelinak redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT badhekaaditya redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT yupriscilla redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT zhangxuemei redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT friedmandavidf redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT kheirjohn redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT vandenboschsarah redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT cabreraantoniog redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT lasajavierj redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT katcoffhannah redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT hupaula redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT borasinosantiago redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT hockkrissie redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT huskeyjordan redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT wellerjamie redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT kothariharsh redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes AT blinderjoshua redbloodcelltransfusionafterstageipalliationisassociatedwithworseclinicaloutcomes |